Ganga Pharmaceuticals Ltd

539680

Summary

Fair Value Assessment
Fair Value Not Available.
Fair ValueQUncertainty
Close Price11.69Feb 27, 2025
Market Closed
11.67
Price Down by 0.02 | 0.17 %
Previous Close
11.69
Day Range
11.67 – 11.67
Year Range
10.92 – 27.10
Bid / Ask
10.51 × 12.77
Market Cap
56.4 Mil
Volume / Average
8.0 k / 28.8 k
Beta (5-Year)
0.29
Shares Outstanding
4.84 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.
Contact
Dhanvantri Marg Gangatat, Gopcharpada, Palghar, MH 401305
T +91 2506098333
www.ayurvedganga.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Sep 30, 2024
Fiscal Year End
Mar 31, 2025
Employees
19

Key Metrics

Income Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
27.28 27.36 25.86 24.89 23.74 30.79
Revenue Growth %
6.80% 5.78% 3.91% 4.83% -22.88% -8.44%
Gross Profit
14.86 14.90 13.47 12.13 11.38 18.02
Gross Profit Margin %
54.49% 54.46% 52.08% 48.73% 47.92% 58.52%
Operating Income
-1.51 0.08 -0.51 -0.13 -0.21 5.35
Operating Margin %
-5.55% 0.31% -1.99% -0.51% -0.87% 17.38%
EBIT
0.49 0.05 -0.58 -0.17 -0.37 3.09
EBIT Margin %
1.80% 0.18% -2.25% -0.69% -1.54% 10.03%
EBITDA
0.94 0.54 -0.02 0.38 0.17 3.63
EBITDA Margin %
3.43% 1.98% -0.08% 1.51% 0.72% 11.78%
Net Income
0.54 0.47 0.39 0.38 0.20 1.89
Net Profit Margin %
2.00% 1.70% 1.52% 1.52% 0.86% 6.13%
Basic EPS
0.12 0.11 0.10 0.09 0.05 0.46
Diluted EPS
0.08 0.07 0.10 0.09 0.05 0.46
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
86.48 86.48 79.84 79.95 76.60 75.67
Total Liabilities
15.95 15.95 25.34 25.84 22.87 22.15
Total Debt
13.58 13.58 18.26 19.28 17.27 14.74
Total Equity
70.53 70.53 54.50 54.11 53.73 53.53
Cash And Cash Equivalents
0.30 0.30 0.29 0.20 0.15 0.12
Working Capital
45.55 45.55 32.53 32.22 29.82 28.02
Shares Outstanding (Mil)
4.84 4.84 4.06 4.06
Book Value Per Share
13.30 13.30 13.42 13.32 13.23 13.18
Total Debt To Equity
0.19 0.19 0.34 0.36 0.32 0.28
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-12.19 -12.64 -0.40 -2.11 -1.75 -3.06
Cash From Investing Activities
5.16 1.30 4.92 1.89 2.76 3.69
Cash From Financing Activities
11.60 11.35 -4.44 0.27 -0.98 -2.88
Capital Expenditures
0.12 0.22 0.15 0.15 0.17 0.10
Free Cash Flow
-3.50 -1.66 -2.20 -1.81 -1.88 0.79
Change in Cash
4.57 0.01 0.09 0.06 0.03 -2.25

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top